102 related articles for article (PubMed ID: 38726737)
1. Homologous polydopamine ameliorates haemolysis of melittin for enhancing its anticancer efficacy.
Zheng Y; Wei Q; Han X; Tao X; Cao T; Chen T; Cao P; Zhan Q
J Mater Chem B; 2024 May; ():. PubMed ID: 38726737
[TBL] [Abstract][Full Text] [Related]
2. Targeted antitumor comparison study between dopamine self-polymerization and traditional synthesis for nanoparticle surface modification in drug delivery.
Zhang M; Zou Y; Zuo C; Ao H; Guo Y; Wang X; Han M
Nanotechnology; 2021 May; 32(30):. PubMed ID: 33862617
[TBL] [Abstract][Full Text] [Related]
3. Enhancing Targeted Therapy in Hepatocellular Carcinoma through a pH-Responsive Delivery System: Folic Acid-Modified Polydopamine-Paclitaxel-Loaded Poly(3-hydroxybutyrate-
Wu M; Wang Q; Peng Y; Liang X; Lv X; Wang S; Zhong C
Mol Pharm; 2024 Feb; 21(2):581-595. PubMed ID: 38131328
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles.
Yan S; Huang Q; Chen J; Song X; Chen Z; Huang M; Xu P; Zhang J
Int J Nanomedicine; 2019; 14():6799-6812. PubMed ID: 31692522
[TBL] [Abstract][Full Text] [Related]
5. Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.
Wang B; Yuan T; Zha L; Liu Y; Chen W; Zhang C; Bao Y; Dong Q
Mol Pharm; 2021 Mar; 18(3):1470-1479. PubMed ID: 33586444
[TBL] [Abstract][Full Text] [Related]
6. Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells.
Mansour GH; El-Magd MA; Mahfouz DH; Abdelhamid IA; Mohamed MF; Ibrahim NS; Hady A Abdel Wahab A; Elzayat EM
Bioorg Chem; 2021 Nov; 116():105329. PubMed ID: 34544028
[TBL] [Abstract][Full Text] [Related]
7. Application of bee venom and its main constituent melittin for cancer treatment.
Liu CC; Hao DJ; Zhang Q; An J; Zhao JJ; Chen B; Zhang LL; Yang H
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1113-1130. PubMed ID: 27677623
[TBL] [Abstract][Full Text] [Related]
8. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy.
Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X
ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681
[TBL] [Abstract][Full Text] [Related]
9. Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast cancer.
Yu R; Zou Y; Liu B; Guo Y; Wang X; Han M
Colloids Surf B Biointerfaces; 2019 May; 177():1-10. PubMed ID: 30690424
[TBL] [Abstract][Full Text] [Related]
10. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
[TBL] [Abstract][Full Text] [Related]
12. Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors.
Zhang M; Zhang F; Liu T; Shao P; Duan L; Yan J; Mu X; Jiang J
Int J Nanomedicine; 2020; 15():10183-10197. PubMed ID: 33363374
[TBL] [Abstract][Full Text] [Related]
13. Photothermal exposure of polydopamine-coated branched Au-Ag nanoparticles induces cell cycle arrest, apoptosis, and autophagy in human bladder cancer cells.
Zhao X; Qi T; Kong C; Hao M; Wang Y; Li J; Liu B; Gao Y; Jiang J
Int J Nanomedicine; 2018; 13():6413-6428. PubMed ID: 30410328
[TBL] [Abstract][Full Text] [Related]
14. NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo-photothermal therapy.
Zhong W; Wong KH; Xu F; Zhao N; Chen M
Acta Biomater; 2022 Jun; 145():135-145. PubMed ID: 35381398
[TBL] [Abstract][Full Text] [Related]
15. Dopamine Receptor-Mediated Binding and Cellular Uptake of Polydopamine-Coated Nanoparticles.
Liu Y; Choi CKK; Hong H; Xiao Y; Kwok ML; Liu H; Tian XY; Choi CHJ
ACS Nano; 2021 Aug; 15(8):13871-13890. PubMed ID: 34379407
[TBL] [Abstract][Full Text] [Related]
16. Combined ROS Responsive Polydopamine-Coated Berberine Nanoparticles Effective Against Ulcerative Colitis in Mouse Model.
Chang C; Liu H; Li X; Song D; Liu Y; Lu C; Zhen Y; Chen Y; Xu J; Li W; Jia X; Chen Z; Chen R
Int J Nanomedicine; 2024; 19():1205-1224. PubMed ID: 38348171
[TBL] [Abstract][Full Text] [Related]
17. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.
Rady I; Siddiqui IA; Rady M; Mukhtar H
Cancer Lett; 2017 Aug; 402():16-31. PubMed ID: 28536009
[TBL] [Abstract][Full Text] [Related]
18. Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment.
Wang Y; Wang Q; Feng W; Yuan Q; Qi X; Chen S; Yao P; Dai Q; Xia P; Zhang D; Sun F
Drug Deliv; 2021 Dec; 28(1):1695-1708. PubMed ID: 34402706
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.
Dong Y; Fu R; Yang J; Ma P; Liang L; Mi Y; Fan D
Int J Nanomedicine; 2019; 14():6971-6988. PubMed ID: 31507319
[TBL] [Abstract][Full Text] [Related]
20. Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer.
Li X; Zou Q; Zhang J; Zhang P; Zhou X; Yalamarty SSK; Liang X; Liu Y; Zheng Q; Gao J
Int J Nanomedicine; 2020; 15():6791-6811. PubMed ID: 32982234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
